Research Article

Amelioration of Sarcoptic Mange-Induced Oxidative Stress and Apoptosis in Dogs by Using Calendula officinalis Flower Extracts

Table 1

Comparison groups A, B, and C for secondary clinical efficacy criterion (SSLS) on days 0, 14, and 28 of therapy.

Groups Days SSLSImprovement (%)

Group A
(Ivermectin + CFE)
015.13 ± 1.46
144.00 ± 1.06a,b73.56
281.50 ± 0.75a,b90.08

Group B
(Ivermectin + NAC)
015.12 ± 2.58
144.12 ± 1.45a,b72.75
281.25 ± 1.03a,b91.73

Group C
(Ivermectin)
015.87 ± 1.35
149.37 ± 2.1940.95
286.13 ± 1.95a61.37

Statistically significant differences ( ), when compared with the day 0 values.
bStatistically significant differences ( ), when compared with the same days values of a group.